Sanofi

5 Stories

Fauci: We Could Have Vaccine This Year
Fauci: We Could Have
Vaccine This Year
the rundown

Fauci: We Could Have Vaccine This Year

He's 'cautiously optimistic'

(Newser) - Dr. Anthony Fauci reaffirmed Friday that the first coronavirus vaccine could be available to Americans before the end of the year. "We hope that as ... we get into the late fall and early winter we will have, in fact, a vaccine that we can say would be safe and...

Year's Most Notable Quote Comes From Rudy Giuliani
Year's Most Notable Quote
Comes From Rudy Giuliani
in case you missed it

Year's Most Notable Quote Comes From Rudy Giuliani

Yale ranks his 'the truth isn't the truth' line as No. 1 for 2018

(Newser) - Yale Law School is out with its annual list of the year's 10 most notable quotes, and it is not President Trump but one of his attorneys, Rudy Giuliani, that has the No. 1 spot. "The truth isn't the truth." Giuliani uttered it to NBC's...

Drugmaker Gets In Roseanne Burn After Ambien Tweet

Barr had blamed racist tweet on the sleep aid

(Newser) - During her tweetstorm about the cancellation of her show and the racist comment that caused it, Roseanne Barr tweeted Tuesday night that "it was 2 in the morning and I was ambien tweeting." (She later deleted the tweet.) Not only did other Twitter users quickly pan that...

Cialis Maker Wants to Sell It Over the Counter

Eli Lilly seeks change for impotence drug

(Newser) - Cialis is already the world's best-selling impotence drug, and its makers hope to significantly ramp up sales by making it available over the counter, reports Reuters . Eli Lilly has struck a deal with French drug-maker Sanofi to sell a non-prescription version, assuming they first win the permission of health...

Experimental Drug Makes High Cholesterol Vanish

Three companies in mad dash in what could be a huge breakthrough: NY Times

(Newser) - Might high cholesterol one day be a thing of the past? A story in the New York Times about an experimental drug suggests as much. Three companies—Amgen, Pfizer and Sanofi—are racing to complete tests and gain approval for their own version. The drug mimics a rare genetic mutation...

5 Stories
Most Read on Newser